Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kelfred HoldingsHKSE:01134 -0.41%45 PB Ratio is 0.81 as of Aug. 20, 2026, which is 48% below its 10-year median of 1.57. GuruFocus rates HKSE:01134 with a GF Score™ of 45/100 and a GF Value™ of HK$0.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 780 Medical Devices & Instruments companies, Kelfred Holdings ranks better than 86.15% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-20), Kelfred Holdings's share price is HK$0.241. Kelfred Holdings's Book Value per Share for the quarter that ended in Dec. 2025 was HK$0.30. Hence, Kelfred Holdings's PB Ratio of today is 0.81.
The historical rank and industry rank for Kelfred Holdings's PB Ratio or its related term are showing as below:
HKSE:01134'
s PB Ratio Range Over the Past 10 Years
Min: 0.55 Med: 1.57 Max: 8.99
Current: 0.8
During the past 10 years, Kelfred Holdings's highest PB Ratio was 8.99. The lowest was 0.55. And the median was 1.57.
HKSE:01134's PB Ratio is ranked better than 86.15% of 780
companies
in the Medical Devices & Instruments industry
Industry Median: 2.135
vs HKSE:01134: 0.80
During the past 12 months, Kelfred Holdings's average Book Value Per Share Growth Rate was -5.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -7.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -4.60% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Kelfred Holdings was 27.00% per year. The lowest was -7.30% per year. And the median was -0.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Kelfred Holdings PB Ratio Related Terms
Kelfred Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for Kelfred Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01134 vs ISRG, BDX, MDLN: PB Ratio Comparison
For the Medical Instruments & Supplies subindustry, Kelfred Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kelfred Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kelfred Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Kelfred Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Kelfred Holdings (HKSE:01134) has a PB Ratio of 0.81 as of Aug. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kelfred Holdings and its competitors. This is 48% below median its historical median of 1.57. Over the past decade, Kelfred Holdings' PB Ratio has ranged from 0.55 to 8.99. According to the industry distribution chart, Kelfred Holdings ranks #108 out of 780 companies in the Medical Devices & Instruments industry, placing it in the top 13.8%.
Is Kelfred Holdings' PB Ratio too high?
Kelfred Holdings' current PB Ratio of 0.81 is 48% below median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 8.99. The Medical Devices & Instruments industry median PB Ratio is 2.14. Kelfred Holdings' value of 0.81 is 62.1% below this industry median. Based on the distribution chart, Kelfred Holdings ranks #108 out of 780 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kelfred Holdings has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kelfred Holdings' PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kelfred Holdings ranks #108 out of 780 companies for PB Ratio. This places Kelfred Holdings in the top 14% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.14. Kelfred Holdings' value of 0.81 is 62.1% below this benchmark. Historically, Kelfred Holdings' own PB Ratio has ranged from 0.55 to 8.99 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 2.14, Kelfred Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.14, based on 780 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kelfred Holdings's current PB Ratio of 0.81 is 62.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kelfred Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kelfred Holdings's current PB Ratio is 0.81, which is 48% below median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelfred Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kelfred Holdings (HKSE:01134) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$0.24 — trading 45.2% below its estimated fair value. The current PB Ratio is 0.81, which is 48% below median its 10-year median of 1.57 and 62.1% below the Medical Devices & Instruments industry median of 2.14. Kelfred Holdings' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Kelfred Holdings (HKSE:01134), the current PB Ratio is 0.81 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kelfred Holdings (HKSE:01134) Overvalued in 2026?
Based on GuruFocus' analysis, Kelfred Holdings stock appears to be undervalued.
The current stock price of HK$0.24 is trading 45.2% below its estimated GF Value™ of HK$0.44.
GuruFocus considers Kelfred Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01134:
PB Ratio: 0.81 (48% below median its 10-year median of 1.57)
GF Value™: HK$0.44 vs. price of HK$0.24 (45.2% below fair value)
Industry Position: 62.1% below the Medical Devices & Instruments median (#108 of 780)
No single metric tells the full story. See the HKSE:01134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kelfred Holdings Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacturing and sales of eyewear products. It produces and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing (ODM) and original equipment manufacturing (OEM) business models. The group offers integrated and customised services, including product design and development, raw materials procurement, production, quality control, packaging, and delivery. The Group also offers (OBM) products under the brand name Miga. It operates in Italy, the United Kingdom, Hong Kong, the U.S., PRC, India, Spain, the Philippines, Japan, Australia, France, and other countries. It generates a majority of its revenue from the United Kingdom.
45GF Score
Get the complete analysis for HKSE:01134
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01134 has been successfully added to your 
